Found: 29
Select item for more details and to access through your institution.
Effects of HIV-1 Serostatus, HIV-1 RNA Concentration, and CD4 Cell Count on the Incidence of Malaria Infection in a Cohort of Adults in Rural Malawi.
- Published in:
- Journal of Infectious Diseases, 2005, v. 192, n. 6, p. 984
- By:
- Publication type:
- Article
HIV-1 Virologic and Immunologic Progression and Initiation of Antiretroviral Therapy among HIV-1--Infected Subjects in a Trial of the Efficacy of Recombinant Glycoprotein 120 Vaccine.
- Published in:
- Journal of Infectious Diseases, 2005, v. 192, n. 6, p. 974, doi. 10.1086/432734
- By:
- Publication type:
- Article
Genetic and Immunologic Characterization of Viruses Infecting MN-rgp120-Vaccinated Volunteers.
- Published in:
- Journal of Infectious Diseases, 1997, v. 176, n. 2, p. 384
- By:
- Publication type:
- Article
Protection of MN-rgp120-immunized chimpanzees from heterologous infection with a primary isolate of human immunodeficiency virus type 1.
- Published in:
- 1996
- By:
- Publication type:
- journal article
Effect of Dose and Immunization Schedule on Immune Response of Baboons to Recombinant Glycoprotein 120 of HIV-1.
- Published in:
- Journal of Infectious Diseases, 1989, v. 160, n. 6, p. 960
- By:
- Publication type:
- Article
CRISPR/Cas9 gene editing for the creation of an MGAT1-deficient CHO cell line to control HIV-1 vaccine glycosylation.
- Published in:
- PLoS Biology, 2018, v. 16, n. 8, p. 1, doi. 10.1371/journal.pbio.2005817
- By:
- Publication type:
- Article
Glycans Flanking the Hypervariable Connecting Peptide between the A and B Strands of the V1/V2 Domain of HIV-1 gp120 Confer Resistance to Antibodies That Neutralize CRF01_AE Viruses.
- Published in:
- PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0119608
- By:
- Publication type:
- Article
Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy Trial.
- Published in:
- PLoS ONE, 2013, v. 8, n. 9, p. 1, doi. 10.1371/journal.pone.0075665
- By:
- Publication type:
- Article
Glycoform and Net Charge Heterogeneity in gp120 Immunogens Used in HIV Vaccine Trials.
- Published in:
- PLoS ONE, 2012, v. 7, n. 8, p. 1, doi. 10.1371/journal.pone.0043903
- By:
- Publication type:
- Article
Monoclonal Antibodies to the V2 Domain of MN-rgp120: Fine Mapping of Epitopes and Inhibition of α4β7 Binding.
- Published in:
- PLoS ONE, 2012, v. 7, n. 6, p. 1, doi. 10.1371/journal.pone.0039045
- By:
- Publication type:
- Article
Phylodynamics of HIV-1 from a Phase III AIDS Vaccine Trial in Bangkok, Thailand.
- Published in:
- PLoS ONE, 2011, v. 6, n. 3, p. 1, doi. 10.1371/journal.pone.0016902
- By:
- Publication type:
- Article
Comparative Immunogenicity of HIV-1 Clade C Envelope Proteins for Prime/Boost Studies.
- Published in:
- PLoS ONE, 2010, v. 5, n. 8, p. 1, doi. 10.1371/journal.pone.0012076
- By:
- Publication type:
- Article
Magnitude and Breadth of a Nonprotective Neutralizing Antibody Response in an Efficacy Trial of a Candidate HIV-1 gpl20 Vaccine.
- Published in:
- Journal of Infectious Diseases, 2010, v. 202, n. 4, p. 595, doi. 10.1086/654816
- By:
- Publication type:
- Article
Secretion of glycosylation site mutants can be rescued by the signal/pro sequence of tissue plasminogen activator.
- Published in:
- Journal of Cellular Biochemistry, 1999, v. 75, n. 3, p. 446, doi. 10.1002/(SICI)1097-4644(19991201)75:3<446::AID-JCB10>3.0.CO;2-I
- By:
- Publication type:
- Article
Biosynthesis and function of membrane bound and secreted forms of recombinant CD11b/CD18 (Mac-1).
- Published in:
- Journal of Cellular Biochemistry, 1993, v. 52, n. 2, p. 183, doi. 10.1002/jcb.240520210
- By:
- Publication type:
- Article
Identification and CRISPR/Cas9 Inactivation of the C1s Protease Responsible for Proteolysis of Recombinant Proteins Produced in CHO Cells.
- Published in:
- Biotechnology & Bioengineering, 2019, v. 116, n. 9, p. 2130, doi. 10.1002/bit.27016
- By:
- Publication type:
- Article
Variable and conserved neutralization antigens of human immunodeficiency virus.
- Published in:
- Nature, 1986, v. 324, n. 6097, p. 572, doi. 10.1038/324572a0
- By:
- Publication type:
- Article
Unusual Cysteine Content in V1 Region of gp120 From an Elite Suppressor That Produces Broadly Neutralizing Antibodies.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.01021
- By:
- Publication type:
- Article
FACTORS AFFECTING THE SUSCEPTIBILITY OF DIFFERENT STRAINS OF MICE TO EXPERIMENTAL MY ASTHENIA GRAVIS*.
- Published in:
- Annals of the New York Academy of Sciences, 1981, v. 377, n. 1, p. 237, doi. 10.1111/j.1749-6632.1981.tb33736.x
- By:
- Publication type:
- Article
Gene editing in CHO cells to prevent proteolysis and enhance glycosylation: Production of HIV envelope proteins as vaccine immunogens.
- Published in:
- PLoS ONE, 2020, v. 15, n. 5, p. 1, doi. 10.1371/journal.pone.0233866
- By:
- Publication type:
- Article
Phylodynamics of HIV-1 from a Phase-III AIDS Vaccine Trial in North America.
- Published in:
- Molecular Biology & Evolution, 2010, v. 27, n. 2, p. 417, doi. 10.1093/molbev/msp254
- By:
- Publication type:
- Article
Vaccine-Induced Env V1-V2 IgG3 Correlates with Lower HIV-1 Infection Risk and Declines Soon After Vaccination.
- Published in:
- Science Translational Medicine, 2014, v. 6, n. 228, p. 1, doi. 10.1126/scitranslmed.3007730
- By:
- Publication type:
- Article
Peptide Targeted by Human Antibodies Associated with HIV Vaccine-Associated Protection Assumes a Dynamic α-Helical Structure.
- Published in:
- PLoS ONE, 2017, v. 12, n. 1, p. 1, doi. 10.1371/journal.pone.0170530
- By:
- Publication type:
- Article
Efficacy of Recombinant Glycoprotein D Subunit Vaccines on the Development of Primary, Recurrent, and Latent Genital Infections with Herpes Simplex Virus Type 2 in Guinea Pigs.
- Published in:
- Journal of Infectious Diseases, 1988, v. 157, n. 5, p. 897, doi. 10.1093/infdis/157.5.897
- By:
- Publication type:
- Article
Ancestral sequences from an elite neutralizer proximal to the development of neutralization resistance as a potential source of HIV vaccine immunogens.
- Published in:
- PLoS ONE, 2019, v. 14, n. 4, p. 1, doi. 10.1371/journal.pone.0213409
- By:
- Publication type:
- Article
Robotic selection for the rapid development of stable CHO cell lines for HIV vaccine production.
- Published in:
- PLoS ONE, 2018, v. 13, n. 8, p. 1, doi. 10.1371/journal.pone.0197656
- By:
- Publication type:
- Article
Glycan modifications to the gp120 immunogens used in the RV144 vaccine trial improve binding to broadly neutralizing antibodies.
- Published in:
- PLoS ONE, 2018, v. 13, n. 4, p. 1, doi. 10.1371/journal.pone.0196370
- By:
- Publication type:
- Article
V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144.
- Published in:
- PLoS ONE, 2017, v. 12, n. 7, p. 1, doi. 10.1371/journal.pone.0180720
- By:
- Publication type:
- Article
Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women.
- Published in:
- PLoS ONE, 2017, v. 12, n. 5, p. 1, doi. 10.1371/journal.pone.0176428
- By:
- Publication type:
- Article